When did Sana Biotechnology report Q4 2024 earnings?

Sana Biotechnology (SANA) reported Q4 2024 earnings on March 17, 2025 before market open.

What were Sana Biotechnology's Q4 2024 revenue and EPS?

Sana Biotechnology reported eps of $-0.23 for Q4 2024.

Did Sana Biotechnology beat estimates in Q4 2024?

EPS beat the consensus estimate of $-0.25 by $0.02.

Where can I find Sana Biotechnology's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000950170-25-040254) directly on SEC EDGAR. The filing index links above go to sec.gov.

Sana Biotechnology SANA Q4 2024 Annual earnings

Reported March 17, 2025 · Before market open

EPS-$0.23Beat by $0.02

EPS estimate-$0.25

Next report

Aug 10, 2026 (In 1 week)

EPS estimate-$0.15

Financials

Q4 2024

Income statement

See full

Operating income-$50.9M+43.9%

Net income-$49.1M+44.3%

EPS (diluted)-$0.21+53.3%

Balance sheet

See full

Cash & equivalents$127.6M-4.5%

Total debt$94.2M-9.5%

Total equity$250.5M-12.9%

Total assets$501.0M-11.4%

Cash flow

See full

Operating cash flow-$47.2M+9.2%

CapEx$436.0K-96.9%

Free cash flow-$47.6M+27.9%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$363.93M-54.8%

Enterprise value$330.56M-57.4%

Returns & leverage

See full

Return on equity-99.2%+60.1pp

Debt / equity0.4×0.0×

Current ratio3.5×+0.2×

Versus estimates

Diluted EPS

Q1 2026-$0.14Beat by $0.01 Q4 2025-$0.16Miss by $0.03 Q3 2025-$0.15Beat by $0.03 Q2 2025-$0.16Beat by $0.04 Q1 2025-$0.20Beat by $0.02

Q4 2024-$0.23Beat by $0.02

Ask the moment Sana Biotechnology reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Sana Biotechnology report Q4 2024 earnings?: Sana Biotechnology (SANA) reported Q4 2024 earnings on March 17, 2025 before market open.
What were Sana Biotechnology's Q4 2024 revenue and EPS?: Sana Biotechnology reported eps of $-0.23 for Q4 2024.
Did Sana Biotechnology beat estimates in Q4 2024?: EPS beat the consensus estimate of $-0.25 by $0.02.
Where can I find Sana Biotechnology's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000950170-25-040254) directly on SEC EDGAR. The filing index links above go to sec.gov.